Skip to main content
. 2013 Dec 2;3:40. doi: 10.1186/2045-7022-3-40

Table 1.

Characteristics peanut sensitized patients that underwent a DBPCFC

No Sex Age
 Peanut-specific-IgE at diagnosis SPT at diagnosis Asthma # Atopic Dermatitis $ Clinical response to DBPCFC GI Resp Syst
(years)
1
 M
 10
 4.0
 <1
 -
 +
 -
  
  
  
2
 M
 15
 0.43
 <1
 +
 +
 -
  
  
  
3
 M
 16
 <0.35
 3
 -
 -
 -
  
  
  
4
 M
 14
 2.0
 2
 -
 -
 -
  
  
  
5
 M
 4
 5.9
 NP
 -
 -
 -
  
  
  
6
 F
 3
 0.6
 3
 -
 +
 -
  
  
  
7
 M
 13
 1.1
 2
 -
 +
 -
  
  
  
8
 M
 4
 7.3
 <1
 +
 +
 -
  
  
  
9
 M
 15
 0.6
 2
 -
 +
 -
  
  
  
10
 M
 4
 97.0
 4
 +
 +
 -
  
  
  
11
 M
 8
 0.8
 3
 -
 -
 -
  
  
  
12
 F
 4
 1.1
 2
 +
 +
 -
  
  
  
13
 M
 5
 >100
 4.5
 -
 +
 +
 +
 +
 +
14
 M
 9
 2.2
 1
 +
 -
 +
 *
 *
 *
15*
 F
 6
 >100
 3
 -
 -
 +
 +
 +
 +
16*
 M
 17
 56.0
 3.5
 -
 +
 +
 -
 +
 -
17
 M
 6
 >100
 4
 +
 -
 +
 +
 -
 -
18
 F
 7
 1.9
 4
 +
 +
 +
 +
 +
 -
19
 M
 4
 3.5
 NP
 -
 +
 +
 +
 +
 +
20
 M
 9
 >100
 3
 +
 -
 +
 +
 +
 +
21
 M
 7
 55.0
 3
 +
 +
 +
 +
 -
 -
22
 F
 7
 2.1
 4
 +
 +
 +
 +
 +
 +
23*
 M
 11
 4.0
 2
 -
 +
 +
 +
 -
 +
24
 M
 4
 6.0
 2
 -
 +
 +
 +
 +
 -
25*
 F
 6
 4.9
 2
 -
 +
 +
 +
 +
 +
26
 M
 7
 15.5
 3
 -
 -
 +
 +
 -
 +
27*
 M
 5
 21.0
 2
 +
 -
 +
 +
 +
 -
28
 F
 6
 5.3
 3
 +
 +
 +
 +
 -
 -
29*
 M
 6
 2.2
 NP
 +
 +
 +
 +
 +
 +
30 F 5 NP 2 - + + - + -

Patient no. 1–12: non-responders to peanut challenge. Patient no. 13–30: positive responders to peanut challenge. # Asthma diagnosed according to ATS criteria.

$Atopic dermatitis diagnosed according to criteria from Hanifin and Rajka. SPT, Skin Prick Test (the number represents the wheal size ratio peanut compared to histamine). DBPCFC, Double-Blind Placebo-Controlled Food Challenge. NP, Not performed. *Children with elevated plasma IL-25 as determined in Figure 1.

GI: Gastrointestinal symptoms including stomach ache, nausea, vomiting and diarrhea; Resp: respiratory symptoms including rhinorrhea, stuffy nose; Syst: systemic symptoms including shortage of breath, systemic urticaria and angioedema.